期刊
FRONTIERS IN IMMUNOLOGY
卷 12, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.729705
关键词
hepatocellular carcinoma; tumor-infiltrating lymphocyte; T lymphocyte; interaction; signaling pathway
类别
资金
- National Natural Science Foundation [81672725]
- Sino-German Cooperation Group [GZ1517]
Primary liver cancer is a common malignancy in China, with liver transplantation, hepatic tumor resection, and molecular-targeted agents being the main treatments. Liver cancer has a poor survival rate and high recurrence rate, with tumor-infiltrating lymphocytes playing essential roles in its development and prognosis. Various subtypes of T lymphocytes have been studied for their roles and mechanisms in liver cancer.
Primary liver cancer (PLC) is one of the most common malignancies in China, where it ranks second in mortality and fifth in morbidity. Currently, liver transplantation, hepatic tumor resection, radiofrequency ablation, and molecular-targeted agents are the major treatments for hepatocellular carcinoma (HCC). Overall, HCC has a poor survival rate and a high recurrence rate. Tumor-infiltrating lymphocytes (TILs) have been discovered to play essential roles in the development, prognosis, and immunotherapy treatment of HCC. As the major component cells of TILs, T cells are also proved to show antitumor and protumor effects in HCC. Foxp3+, CD8+, CD3+, and CD4+ T lymphocytes are the broadly studied subgroups of TILs. This article reviews the roles and mechanisms of different tumor-infiltrating T lymphocyte subtypes in HCC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据